Analysis of CSF proteins is useful in the diagnosis and management of neurological diseases in the following situations:
In inflammatory conditions when there is breakdown of blood-CSF barrier integrity. Meningitis is a medical emergency, with CSF total protein measurement being only a screening test.
In the detection of immune responses within the CNS. This is by far the most important application in a routine clinical setting, as it is now a firmly established criterion in the diagnosis of multiple sclerosis. Oligoclonal bands restricted to the CSF are the only reliable indicators of intrathecal immunoglobulin G synthesis and are practically always associated with inflammatory disease of the CNS. The method of choice for detecting oligoclonal bands is isoelectric focusing with immunofixation. Quantitative measurement of IgG in the CSF is of no value in diagnostic pathology.
In destructive brain diseases when brain-specific proteins are released into the CSF, measurement of these proteins can give prognostic information.
ThompsonRJ. Human Nervous System Specific Proteins. In: AlbertiKGMMPriceCP, eds. Recent Advances in Clinical Biochemistry, Edinburgh: Churchill Livingstone, 1981: 295–307.
2.
LowenthalACrolsRDe SchutterECerebrospinal fluid proteins in neurology. Int Rev Neurobiol1984; 25: 95–138.
3.
CutlerRWPPageLGalicichJWattersGV. Formation and absorption of cerebrospinal fluid in man. Brain1968; 91: 707–20.
4.
RubinRCHendersonESWalkerMDRallDP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg1966; 25: 430–6.
5.
FrickEScheid-SeydelL.Untersuchungen mit J 131-markeitem albumin uber austauschvorgange zwischen plasma und liquor cerebrospinalis. Klin Wochensch, 1958; 36: 66–9.
6.
TourtellotteWWPotvinARFlemingJOMultiple sclerosis: Measurement and validation of central nervous system IgG synthesis rate. Neurology1980; 30: 240–4.
7.
MilhoratTHHammockMKFenstermacherJDLevinVA. Cerebrospinal fluid production by the choroid plexus and brain. Science1971; 173: 330–2.
8.
SatoOBeringEA. Extra-ventricular formation of cerebrospinal fluid. Brain Nerve1967; 17: 883–5.
9.
RapoportSI. Passage of proteins from blood to cerebrospinal fluid. In WoodJH, ed. Neurobiology of Cerebrospinal Fluid, Vol. 2. New York: Plenum Press, 1983: 233–45.
10.
OlssonY.Studies on the vascular permeability in peripheral nerves. Acta Neuropath1971; 17: 114–26.
11.
FelgenhauerKRennerE.Hydrodynamic radii versus molecular weight in clearance studies of urine and cerebrospinal fluid. Ann Clin Biochem1977; 14: 100–4.
12.
GriffenDEGiffelsJ.Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J Clin Invest1982; 70: 289–95.
13.
FelgenhauerK.Protein size and cerebrospinal fluid composition. Klin Wochenschr1974; 52: 1158–64.
14.
FishmanRARansohoffJOssermanEF. Factors influencing the concentration gradient of protein in cerebrospinal fluid. J Clin Invest1958; 37: 1419–24.
15.
JefferiesWABrandonMRHuntSVWilliamsAFGatterKCMasonDY. Transferrin receptors on the endothelium of brain capillaries. Nature1984; 312: 162–3.
16.
ThompsonEJ. The CSF Proteins: A Biochemical Approach. Amsterdam, Elsevier, 1988: 43–4.
17.
DicksonPWAldredARMarleyPDGuo-FenTHowlettGJSchreiberG.High prealbumin and transferrin mRNA levels in the choroid plexus of rat brain. Biochem Biophys Res Commun1985; 127: 890–5.
18.
ThompsonEJ. Immunochemistry of CSF proteins. In: WardMilford AWhicherJT, eds. Immunochemistry in Clinical Laboratory Medicine. Lancaster: MTP Press1979: 229–36.
19.
WeisnerBBernhardtW.Protein fraction of lumbar, cisternal and ventricular cerebrospinal fluid. J Neurol Sci1978; 37: 205–14.
20.
WeisnerBRoethigH-J.The concentration of prealbumin in cerebrospinal fluid (CSF), indicator of CSF circulation disorders. Eur Neurol1983; 22: 96–105.
21.
ProckopLDSchankerLSBrodieBB. Passage of lipid insoluble substances from cerebrospinal fluid to blood. J Pharmacol Exp Ther1962; 135: 266–70.
22.
FelgenhauerK.Protein filtration and secretion at human body fluid barriers. Pflugers Arch1980; 384: 9–17.
23.
FelgenhauerKSchliepGRapicN.Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system. J Neurol Sci1976; 30: 113–28.
24.
FelgenhauerK.Vergleichende Disc-electrophorese von Serum und Liquor Cerebrospinalis. Stutgard: Thieme, 1971: 1–65.
25.
JohnsonMHThompsonEJ. Measurement of body fluid proteins by polyacrylamide gel electrophoresis. J Clin Pathol1982; 35: 1328–33.
26.
LaterreFC. Les Proteines du Liquide Cephalorachidien a l'Etat Normal et Pathological. Brussels: Arscia, 1965: 1–327.
27.
MartonKIGeanAD. The spinal tap: A new look at an old test. Ann Int Med1986; 104: 840–8.
28.
HaywardRAShapiroMFOyeRK. Laboratory testing on cerebrospinal fluid. Lancet1987; i:1–4.
29.
StatzAFelgenhauerK.Development of the blood-CSF barrier. Dev Med Child Neurol1983; 25: 152–61.
30.
TibblingGLinkHOhmanS.Principles of albumin and IgG analysis in neurological disorders I. Establishment of reference values. Scand J Clin Lab Invest1977; 37: 385–90.
31.
KleineTOBaerlocherKNiedererVDiagnostische bedeutung der lactatbestimmung im liquor bei meningitis. Dtsch med Wochenschr1979; 104: 553–7.
32.
Van ZantenAPTwinjstraAde VisserOngerboer BW. Routine investigations of the CSF with special reference to meningeal malignancy and infectious meningitis. Acta Neurol Scand1988; 77: 210–4.
33.
PeltolaHO. C-reactive protein for rapid monitoring of infections of the central nervous system. Lancet1982; i: 980–3.
34.
SindicCJMCollet-CassartDDepareALaterreECMassonPL. C-reactive protein in serum and cerebrospinal fluid in various neurological disorders. J Neurol Sci1984; 63: 339–44.
35.
CorrallCJPeppleJMMoxonERHughesWT. C-reactive protein in spinal fluid of children with meningitis. J Paediatr1981; 99: 365–9.
36.
CurtisGDWSlackMPETomkinsDS. Cerebrospinal fluid lactate and the diagnosis of meningitisJ Infect1981; 3: 159–65.
37.
HornigCRBusseODorndorfWKapsM.Changes in CSF blood-brain barrier parameters in ischaemic cerebral infarction. J Neurol1983: 229; 11–16.
38.
SchliepGFelgenhauerK.Serum-CSF protein gradients, the blood-CSF barrier and the local immune response. J Neurol1978; 218: 77–96.
39.
KeirGThompsonEJ. Proteins as parameters in the discrimination between different blood-CSF barriers. J Neurol Sci1986; 75: 245–53.
40.
Al-KassabSOlsenTSSkriverEB. Blood-brain barrier integrity in patients with cerebral infarction investigated by computed tomography and serum/CSF albumin. Acta Neurol Scand1981; 64: 438–45.
41.
DelpechBLichtblauE.Etude quantiative des immunoglobulines G et de l'albumine du liquide cephalo rachidien. Clin Chim Acta1972; 37: 15–23.
42.
LinkHTibblingG.Principles of albumin and IgG analysis in neurological disorders II. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest1977; 37: 397–401.
43.
GanrotKLaurellC-B.Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem1974; 20: 571–3.
44.
FelgenhauerK.Differentiation of the humoral immune response in inflammatory diseases of the central nervous system. J Neurol1982; 228: 223–37.
45.
BaarkJ-PBergOHwemmingsenL.Immunonephelometric determination of proteins in cerebrospinal fluid in various neurological disorders. Clin Chim Acta1983; 127: 271–7.
46.
WardMilford A. (ed). PRU Handbook of Clinical Immunochemistry, 2nd Edition. Sheffield: PRU Publications1988: 64–8.
47.
LefvertAKLinkH.IgG production within the central nervous system: A critical review of proposed formulae. Ann Neurol1985; 17: 13–20.
48.
SchullerEACBenabdallahSSagarHJReboulJAMTompeLC. IgG synthesis within the central nervous system. comparison of three formulas. Arch Neurol1987; 44: 600–4.
49.
Dhib-JalbutSAbdelnoorAHaddadFS. Intracerebral IgG synthesis in subacute sclerosing panencephalitis as evaluated from CSF analysis. Saudi Med J1984; 5: 310–4.
50.
TourtellotteWWStaugaitisSMWalshMJThe basis of intra-blood-brain-barrier IgG synthesis. Ann Neurol1985; 17: 21–7.
51.
ReiberHFelgenhauerK.Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta1987; 163: 319–28.
52.
McLeanBNLuxtonRWThompsonEJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isolectric focusing and the log IgG index: A comparison and diagnostic applications. Brain: in press.
53.
ThompsonEJRichesPGKohnJ.Antibody synthesis within the central nervous system: Comparisons of CSF IgG indices and electrophoresis. J Clin Pathol1983; 36: 312–5.
54.
LinkHMullerR.Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol1971; 25: 326–44.
55.
GersonBCohenSRGersonIMGuestGH. Myelin basic protein, oligoclonal bands, and IgG in cerebrospinal fluid as indicators of multiple sclerosis. Clin Chem1981; 27: 1974–7.
56.
HersheyLATrotterJL. The use and abuse of the cerebrospinal IgG profile in the adult: A practical evaluation. Ann Neurol1980; 8: 426–34.
57.
LivreaPTrojanoMSimoneILZimatoreGBLamontanaraGLeanteR.Intrathecal IgG synthesis in multiple sclerosis: Comparisons between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgG. J Neurol1981; 224: 159–69.
58.
LinkH.Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin Chim Acta1973; 46: 383–9.
59.
DelmotteP.Resultats comparatifs de l'electrophorese en agar et de l'examen par electrofocalisation des gammaglobulines du liquide cephalorachidien. Acta Neurol Belg1972; 72: 226–34.
60.
LaurenziMALinkH.Comparison between agarose gel electrophoresis and isolectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders. Acta Neurol Scand1978; 58: 148–56.
61.
KeirGChowhanMRThompsonEJ. High electroendosmotic agarose electrophoresis and nitrocellulose immobilisation for the detection of oligoclonal bands in unconcentrated cerebrospinal fluid. Ann Clin Biochem1985; 22: 381–6.
62.
VandvikBSkredeS.Electrophoretic examination of cerebrospinal fluid proteins in multiple sclerosis and other neurological diseases. Europ Neurol1973; 9: 224–41.
63.
GoodlandFThompsonEJ. A comparison of cellulose acetate immunofixation with polyacrylamide gel electrophoresis for the detection of oligoclonal bands in unconcentrated CSF. J Clin Pathol1983; 36: 1309–11.
64.
ThompsonEJKaufmannPShortmanRCRudgePMcDonaldWI. Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. Br Med J1979; 1: 16–7.
65.
DelmottePGonsetteR.Biochemical findings in multiple sclerosis. IV. Isoelectric focusing of the CSF gamma globulins in multiple sclerosis (262 cases) and other neurological diseases (272 cases). J Neurol1977; 215: 27–37.
66.
KjellinKGHallanderLB. High voltage isoelectric focusing in gels and enzyme-amplified immunoassay: A new method for analysis of cerebrospinal fluid proteins. J Neurol1982; 228: 49–57.
67.
WalkerRWHKeirGJohnsonMHThompsonEJ. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol1983; 4: 141–8.
68.
LinkHKostulasV.Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients. Clin Chem1983; 29: 810–5.
69.
OlssonTKostulosVLinkH.Improved detection of oligoclonal IgG in cerebrospinal fluid by isolectric focusing in agarose, double antibody peroxidase labelling, and avidin-biotin amplification. Clin Chem1984; 30: 1246–9.
70.
LinkH.Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Acta Neurol Scand1967; 28: 1–135.
71.
LaurellC-B.On the origin of major CSF proteins. In: ThompsonEJ ed. Advances in CSF Protein Research and Diagnosis. Lancaster: MTP Press1987: 123–8.
72.
BarrettAJDaviesMEGrubbA.The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Comm1984; 120: 631–6.
73.
Van Den RoosFAJTMRoosRA. Gel isoelectric focusing and IgG index for demonstration of intrathecal IgG synthesis in neurological disorders. Ann Clin Biochem1981; 18: 153–7.
74.
GalloPBraccoFTavolatoB.Blood-brain barrier damage restricts the reliability of quantitative formulae and isoelectric focusing in detecting intrathecally synthesised IgG. J Neurol Sci1988; 84: 87–93.
75.
MattsonDHRoosRPArnasonBGW. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature1980; 287: 335–7.
76.
Sandberg-WollheimM.Immunoglobulin synthesis in vitro by cerebrospinal fluid cells in patients with multiple sclerosis. Scand J Immunol1974; 3: 717–30.
77.
TourtellotteWW. The cerebrospinal fluid in multiple sclerosis In: KoetsierJC, ed. Handbook of Clinical Neurology (Revised Series) Volume 3 (47): Demyelinating Disorders Amsterdam: Elsevier1985, pp 79–130.
78.
ThompsonEJKaufmannPRudgeP.Sequential changes in oligoclonal patterns during the course of multiple sclerosis. J Neurol Neurosurg Psychiatr1983; 46: 115–8.
79.
VandvikB.Oligoclonal IgG and free light chains in the cerebrospinal fluid of patients with multiple sclerosis and infectious diseases of the central nervous system. Scand J Immunol1977; 5: 913–92.
80.
Stendahl-BrodinLLinkH.Optic neuritis: Oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol Scand1983; 67: 301–4.
81.
ErsmarkBSidenA.Isoelectric focusing of CSF proteins and the future evolution of multiple sclerosis: A clinical follow-up. J Neurol1984; 231: 117–21.
82.
MoulinDPatyDWEbersGC. The predictive value of cerebrospinal fluid electrophoresis in ‘possible’ multiple sclerosis. Brain1983; 106: 809–16.
83.
RudickRASchifferRBSchwetzKMHerndonRM. Multiple sclerosis. The problem of incorrect diagnosis. Arch Neurol1986; 43: 578–83.
84.
KeirGWalkerRWHThompsonEJ. Oligoclonal immunoglobulin M in cerebrospinal fluid from multiple sclerosis patients. J Neurol Sci1982; 57: 281–5.
85.
ShariefMKKeirGThompsonEJ. Glutaraldehyde-enhanced immunofixation: A sensitive new method for detecting oligoclonal immunoglobulin M. J Neuroimmunol1989; 23: 149–56.
86.
VandvikBNorrbyESteen-JohnsenJStensvoldK.Mumps meningitis: Prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid. Eur Neurol1978; 17: 13–22.
87.
BollengierFLowenthalAHenrotinW.Bound and free light chains in subacute sclerosing panencephalitis and multiple sclerosis serum and cerebrospinal fluid. Z Klin Chem Klin Biochem1975; 13: 305–10.
88.
BollengierFRabinovitchNLowenthalA.Oligoclonal immunoglobulins, light chain ratios and free light chains in cerebrospinal fluid and serum from patients affected with various neurological diseases. Z Klin Chem Klin Biochem1978; 16: 165–73.
89.
VakaetAThompsonEJ. Free light chains in the cerebrospinal fluid: An indicator of recent immunoglobical stimulation. J Neurol Neurosurg Psychiatr1985; 48: 995–8.
FagnartOCSindicCJMLaterreC.Free kappa and lambda light chain levels in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J Neuroimmunol1988; 19: 119–2.
92.
GalloPTavolatoBBergenbrandtSSidenA.Immunoglobulin light chain patterns in the cerebrospinal fluid. A study with special reference to the occurrence of free light chains in cerebrospinal fluid with and without oligoclonal immunoglobulin G. J Neurol Sci1989; 94: 241–53.
93.
CompstonDASMilliganNMHughesPJA double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. laboratory results. J Neurol Neurosurg Psychiatr1987; 50: 517–22.
94.
VerjansETheysPDelmottePCartonH.Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I. J Neurol1983; 229: 155–65.
95.
WalkerRWHThompsonEJMacDonaldWI. Cerebrospinal fluid in multiple sclerosis: Relationship between immunoglobulins, leucocytes and clinical features. J Neurol1985; 232: 250–9.
96.
PoserCMPatyDScheinbergLNew diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol1983; 13: 227–31.
97.
KeirGLuxtonRLThompsonEJ. Isoelectric focusing of CSF immunoglobulin G: An annotated update. Ann Clin Biochem1990; 27: 436–443.
